Followers | 101 |
Posts | 13186 |
Boards Moderated | 0 |
Alias Born | 06/01/2013 |
Saturday, September 12, 2020 11:53:32 AM
Odile Launay, MD
Universite Paris Descartes, Sorbonne Paris Cit ´ e, H´ opital Cochin, CIC de Vaccinologie Cochin Pasteur, Paris, France
https://watermark.silverchair.com/jtm20-0275.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAqAwggKcBgkqhkiG9w0BBwagggKNMIICiQIBADCCAoIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMY_LlKr_lRdZOuY3zAgEQgIICU0HpIN5j3HpWu8W-AoDAaOVlTPcMG44l1ymfFoBSXug2EWa1Fy5noDI8cCu_dAKIP30sWcOb0gveCXEqYRpsuMHsuz4WtH3eEcYG2QxK-7VFO2ujmIPJC8z5HtSEpKbg4WPaYrjORGk4ywZWPlWMf0TppDPcpZ6zTHGCj5pXDBeupckc4IGzNQ9WkIRKUVAgAQxiNe2mm6Yx0bonDfh24-R5nDcgbaES_tqu0KYLjs9x9c5Aj2DGx30WH6ex0pfA_0vhLGudcpNcrJCXsueHEPOJ-eZqe8_KVGQNEWaia7lhNwRONkDLJNJuYTYn2dceRttcwLL3q_X84SgdyAlwBZNR4v0GfZanCLx6NwuBTSgVfjOFNu1lvTz6DO-T7VNRcgMdd_KNNqIzQiJwT4W9ydjF3S1yaQJ2jT4CKPxFho9-9mkGwXYTwaTbbAvL7eUM40IhXNu-q93HSG9p3-W6qpXzPzCCrTcoLnCje8gPW9sSid1gzNg-Jsygc428BOfFuPMDqdgwPCdHBXcH9ZE9f6JVu8ZAcUIrXziAiiDh3xxdYmr2Ng7ZiaXuv9IgVmjVvRwflKMhnkkPvifVYshQ2qBy5vJ_hw3tVp8E0yGxg1Sy0ZEWS1se64o1JCiPeIe9-aV-8S9efXXSbfyG7UEpCX36fA_Hl8H_8gzW5h60rPGpxzaS4Zj_5Uxhfn1EobH3EGPzyEI1iJrP7uweXn41OqHz57e4TOzmx6Vq_2b6LOrJQ300tonbpmlAbRUFt8nWtWgL0M4ZEpvMZkgQ049TqUd2Yck
Furthermore, the IVE was calculated on the basis of ORs determined using a random effects model, which allowed us to take into account potential differences, including type of vaccine, vaccination programs, the levels of immunity across different population and settings, and different use of hospital emergency departments [36], [37].
37.Puig-Barbera J, Natividad-Sancho A, Calabuig-Perez J, Lluch-Rodrigo JA, Pastor-Villalba E, et al. (2013) MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system. Vaccine 31: 3995–4002.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0100497
Vaccination against viral hepatitis of HIV-1 infected patients
the immunogenicity of a virosome-formulated HAV vaccine (Epaxal®, Berna Biotech Ltd.) has been evaluated, in 14 HIV-positive adults and 64 healthy adults, who received a primary immunisation (1 dose at day 1) and a booster dose 12 mo later.28
https://www.tandfonline.com/doi/full/10.4161/hv.19105
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM